**Core Concept**
The question is testing the student's knowledge of the malignant potential of different types of tumors, specifically in the context of breast cancer. The underlying concept being tested is the relative aggressiveness and potential for metastasis of various tumor types.

**Why the Correct Answer is Right**
The malignant potential of a tumor is determined by its ability to invade surrounding tissues and metastasize to distant sites. In breast cancer, the most aggressive and malignant tumors are those that are high-grade, estrogen receptor-negative, and HER2-positive. Among the various types of breast cancer, triple-negative breast cancer (TNBC) has the highest malignant potential due to its aggressive growth pattern, high rate of metastasis, and limited treatment options. TNBC lacks estrogen receptors, progesterone receptors, and excess HER2 protein, making it resistant to hormone therapy and targeted therapies.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because while ductal carcinoma in situ (DCIS) is a type of non-invasive breast cancer, it is not as aggressive as TNBC and has a lower malignant potential.

**Option B:** This option is incorrect because while invasive lobular carcinoma (ILC) is a type of invasive breast cancer, it is not as aggressive as TNBC and has a lower malignant potential.

**Option C:** This option is incorrect because while inflammatory breast cancer (IBC) is a type of aggressive breast cancer, it is not as common as TNBC and has a lower malignant potential.

**Clinical Pearl / High-Yield Fact**
TNBC accounts for approximately 10-15% of all breast cancers and tends to affect younger women, African American women, and those with a family history of breast cancer. It is essential to recognize the high malignant potential of TNBC and to consider aggressive treatment options, including neoadjuvant chemotherapy and radiation therapy.

**Correct Answer:** D.